SUPN
USDSupernus Pharmaceuticals Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$55.430
고가
$57.400
저가
$54.610
거래량
4.00M
기업 기본 정보
시가총액
3.2B
산업
Drug Manufacturers - Specialty & Generic
국가
United States
거래 통계
평균 거래량
0.82M
거래소
NGM
통화
USD
52주 범위
관련 뉴스
B of A Securities Initiates Coverage On Supernus Pharmaceuticals with Buy Rating, Announces Price Target of $65
B of A Securities analyst Pavan Patel initiates coverage on Supernus Pharmaceuticals with a Buy rating and announces Price Target of $65.
TD Cowen Maintains Buy on Supernus Pharmaceuticals, Raises Price Target to $60
TD Cowen analyst Stacy Ku maintains Supernus Pharmaceuticals with a Buy and raises the price target from $45 to $60.
Supernus Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
ROCKVILLE, Md., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system
Piper Sandler Upgrades Supernus Pharmaceuticals to Overweight, Raises Price Target to $65
Piper Sandler analyst David Amsellem upgrades Supernus Pharmaceuticals from Neutral to Overweight and raises the price target from $40 to $65.
